Pembrolizumab as first-line treatment for non-small cell lung cancer-a game changer?

被引：4
作者：
Dempke, Wolfram C. M. [1 ,2 ]
Fenchel, Klaus [3 ]
机构：
[1] Kyowa Kirin Pharmaceut Dev Ltd, Dept Med Oncol, Galabank Business Pk, Galashiels TD1 1QH, Scotland
[2] Univ Munich, Univ Hosp Grosshadern, Dept Haematol & Oncol, Munich, Germany
[3] Med Sch Hamburg, Dept Med, Hamburg, Germany
来源：
TRANSLATIONAL LUNG CANCER RESEARCH | 2016年 / 5卷 / 05期
关键词：
PHASE-III; NIVOLUMAB; CHEMOTHERAPY; DOCETAXEL; CISPLATIN;
D O I：
10.21037/tlcr.2016.10.01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：538 / 542
页数：5
相关论文
共 17 条
  • [1] Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
    Borghaei, H.
    Paz-Ares, L.
    Horn, L.
    Spigel, D. R.
    Steins, M.
    Ready, N. E.
    Chow, L. Q.
    Vokes, E. E.
    Felip, E.
    Holgado, E.
    Barlesi, F.
    Kohlhaeufl, M.
    Arrieta, O.
    Burgio, M. A.
    Fayette, J.
    Lena, H.
    Poddubskaya, E.
    Gerber, D. E.
    Gettinger, S. N.
    Rudin, C. M.
    Rizvi, N.
    Crino, L.
    Blumenschein, G. R.
    Antonia, S. J.
    Dorange, C.
    Harbison, C. T.
    Finckenstein, F. Graf
    Brahmer, J. R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (17) : 1627 - 1639
  • [2] Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
    Brahmer, Julie
    Reckamp, Karen L.
    Baas, Paul
    Crino, Lucio
    Eberhardt, Wilfried E. E.
    Poddubskaya, Elena
    Antonia, Scott
    Pluzanski, Adam
    Vokes, Everett E.
    Holgado, Esther
    Waterhouse, David
    Ready, Neal
    Gainor, Justin
    Aren Frontera, Osvaldo
    Havel, Libor
    Steins, Martin
    Garassino, Marina C.
    Aerts, Joachim G.
    Domine, Manuel
    Paz-Ares, Luis
    Reck, Martin
    Baudelet, Christine
    Harbison, Christopher T.
    Lestini, Brian
    Spigel, David R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (02) : 123 - 135
  • [3] Dempke WCM, 2015, ANTICANCER RES, V35, P5745
  • [4] Moving Programmed Death-1 Inhibitors to the Front Lines in Non-Small-Cell Lung Cancer
    Gainor, Justin F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (25) : 2953 - +
  • [5] Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
    Garon, Edward B.
    Rizvi, Naiyer A.
    Hui, Rina
    Leighl, Natasha
    Balmanoukian, Ani S.
    Eder, Joseph Paul
    Patnaik, Amita
    Aggarwal, Charu
    Gubens, Matthew
    Horn, Leora
    Carcereny, Enric
    Ahn, Myung-Ju
    Felip, Enriqueta
    Lee, Jong-Seok
    Hellmann, Matthew D.
    Hamid, Omid
    Goldman, Jonathan W.
    Soria, Jean-Charles
    Dolled-Filhart, Marisa
    Rutledge, Ruth Z.
    Zhang, Jin
    Lunceford, Jared K.
    Rangwala, Reshma
    Lubiniecki, Gregory M.
    Roach, Charlotte
    Emancipator, Kenneth
    Gandhi, Leena
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (21) : 2018 - 2028
  • [6] Nivolumab Monotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer
    Gettinger, Scott
    Rizvi, Naiyer A.
    Chow, Laura Q.
    Borghaei, Hossein
    Brahmer, Julie
    Ready, Neal
    Gerber, David E.
    Shepherd, Frances A.
    Antonia, Scott
    Goldman, JonathanW.
    Juergens, Rosalyn A.
    Laurie, Scott A.
    Nathan, Faith E.
    Shen, Yun
    Harbison, Christopher T.
    Hellmann, Matthew D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (25) : 2980 - +
  • [7] Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
    Herbst, Roy S.
    Baas, Paul
    Kim, Dong-Wan
    Felip, Enriqueta
    Perez-Gracia, Jose L.
    Han, Ji-Youn
    Molina, Julian
    Kim, Joo-Hang
    Arvis, Catherine Dubos
    Ahn, Myung-Ju
    Majem, Margarita
    Fidler, Mary J.
    de Castro, Gilberto, Jr.
    Garrido, Marcelo
    Lubiniecki, Gregory M.
    Shentu, Yue
    Im, Ellie
    Dolled-Filhart, Marisa
    Garon, Edward B.
    [J]. LANCET, 2016, 387 (10027) : 1540 - 1550
  • [8] Advances in the Treatment of Non-small Cell Lung Cancer: Focus on Nivolumab, Pembrolizumab, and Atezolizumab
    Leventakos, Konstantinos
    Mansfield, Aaron S.
    [J]. BIODRUGS, 2016, 30 (05) : 397 - 405
  • [9] PARAMOUNT: Final Overall Survival Results of the Phase III Study of Maintenance Pemetrexed Versus Placebo Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non-Small-Cell Lung Cancer
    Paz-Ares, Luis G.
    de Marinis, Filippo
    Dediu, Mircea
    Thomas, Michael
    Pujol, Jean-Louis
    Bidoli, Paolo
    Molinier, Olivier
    Sahoo, Tarini Prasad
    Laack, Eckart
    Reck, Martin
    Corral, Jesus
    Melemed, Symantha
    John, William
    Chouaki, Nadia
    Zimmermann, Annamaria H.
    Visseren-Grul, Carla
    Gridelli, Cesare
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (23) : 2895 - +
  • [10] Systemic chemotherapy for advanced non-small cell lung cancer: Recent advances and future directions
    Ramalingam, Suresh
    Belani, Chandra
    [J]. ONCOLOGIST, 2008, 13 : 5 - 13
12